LISTSERV 16.0 - PARKINSN Archives

Subscriber's Corner

Email Lists

PARKINSN Archives

PARKINSN@LISTSERV.UTORONTO.CA

View:

Message:

[

First

Last

]

By Topic:

[

First

Last

]

By Author:

[

First

Last

]

Font:

Monospaced Font

		LISTSERV Archives
		PARKINSN Home
		PARKINSN August 1997, Week 5

Subject:

CSRINDX Part 1

From:

"J. R. Bruman" <[log in to unmask]>

Reply-To:

[log in to unmask]

Date:

Mon, 1 Sep 1997 13:39:05 -0400

Content-Type:

text/plain

Parts/Attachments:

text/plain (249 lines)

I N D E X , C U R R E N T

NOTICE: This Index to past with each new monthly posting cumulative, you may safely are posted for the benefit status of PD research. For what this is all about, please
     SUBJECT        Absorption, levodopa Jun 96 Neurology Acetazolamide (Diamox) Nov 95 Movement Disorders      " Acetyl-L Carnitine Oct 96 Neur ADHD, and dopamine Sep 96 Lancet Agonists, action May 95 Neur Albuterol Dec 94 Neur Alternative medicine Oct 96 British Medical J Alzheimer's and PD Apr 95 Annals of Neur      " Amantadine (Symmetrel) Jul 96 Neur Aminophylline Sep Anticipation Feb 97 Neur Antioxidants, dietary May 97 Mov Disord Appetite increase Aug 97 Neur Apolipoprotein E Nov Apomorphine, PD effcts Dec      "      "      "      "      ",      ", and libido Apoptosis Feb 96 Ann Neur      "      "      "      "      " Aptiganel Sep 97 J Clin Neuropharm Artane, withdrawal Mar 97 Ann Neur Autonomous deficit Apr 97 Neur Axial motor control Feb Behavioral treatment Aug 97 Mov Disord Blink reflex, and PD Dec 96 J Neurosci Botulinum toxin Jun 96 Neur      "      " Boxers, parkinsonism Jul Brain injury Jan 97 Neur Bradykinesia Sep 96 Brain Bromocryptine Dec      "      " Bruxism Feb 97 Mov Disord Cabergoline Jan 95 Arch Neur      "      "      " Calcium deficiency Sep 97 Mov Disord Carbidopa, stability Sep 97 Mov Disord Carnitine, Acetyl-L Oct 96 Neur Cerebellum, in ET Jun 96 Neur      "      " Chocolate and red wine Oct 96 Lancet Cinnarizine Feb 97 Mov Disord Cisapride Aug 97 Mov Disord Clonidine Aug 97 Lancet Clozapine (Clozaril) Apr 95 Lancet      "      "      "      "      "      "      " for tremor      " lit. review Cocaine, effect Jan 97 J Neurosci Cognitive decline Feb      "      "      "      "      "      " Color discrimination Mar 95 Neur       " Complex I (enzyme) Nov 96 Ann Neur       " Constipation Nov 95 Lancet      " DATATOP Nov 95 Arch Neur      "      "      " Deep-brain stimulation Oct 1996;53:898-903 " 1996;46:1150-1153
     "      "      "      " for ET Dementia, PD vs AD Jul 95 Neur      " , Downs and      "      "      " , incidence      " ,      "      " Depression Mar 96 Arch Neur      "      " Diagnosis, clinical Apr 97 Brain      " ,      " , Dimethyl Selegiline Aug 97 J Neurochem DLBD Jun   " ,FD-PET diagnosis Dopamine, non-PD use Apr 97 BMJ      "      "      "      "      "      "      " Down's syndrome Feb 95 Neur Driving ability Feb 96 JAMA      " Drug Industry hype Nov 96 Time      " Drug strategy Aug 97 Neur Dyskinesia Jul 96 Neur      "      "      " Eldepryl (selegiline) Dec 94 Ann Neur Electroconvulsive (PSP)Jun 96 Neur      " Encephalitis, childhoodJun Entacapone Feb      " Enteric nervous system Jun 96 New England J Med Essential tremor, VIM Jun 96 Neur      "      "      "      "      "      "      "      "      "      "      "      "      "      " Ethanol and ET Jun 96 Ann Neur      " Etiology of PD Jun 96 Neur      "      "      "      "      "      "      "      " Expression Jan 96 Neur Eye movement Jan 95 Neur Fetal transplant Oct 95 Ann Neur      "      "      " , fatal      " , FDA and      " ,(pig)      " , "      " , "      " , "      " , "      "      "      " , effects      "      " , Fluctuations, motor Aug 97 Mov Disord Fluctuations, nonmotor Jan 97 Neur Flunarizine Feb 97 Movem't Dis Food And Drug Adm. Jul 97 Nat Med Food habits and PD Oct 96 Neur Free radicals Jun 96 Science News Freezing, in non-IPD Aug 97 Mov Disord Freezing, help for May 97 Mov Disord Gabapentin for RLS May 97 J Clin Neuropharm      " Gait, improvement Jul 96 Brain   " impairment   " " Gamma knife Jun 96 Ann Neur Ganglioside GM1 Sep 95 Neur GDNF Dec 96 J Neurosci   "   "   " Gene CYP2D6, and risk Sep 96 Neur Gene, mutation Jun 95 Lancet      "      "      "      "      "      "      "      " Gene transfer Aug 95 Science News      "      "      " Glucose tolerance Jan 96 Int J Neur Glutamate antagonist Jun 96 Ann Neur      "      "      "      "      " Glutamic acid RNA Sep 96 Neur Guillain-Barre Sep 95 Ann Neur Hallucinations Jun 96 Neur      "      " Heredity Apr 95 Neur      "      "      "      "      "      "      " Histaminergic neurons Jul 96 Neur
J. R. Bruman (818) 789-3694
3527 Cody Road
Sherman Oaks, CA 91403-5013 S C I E N C E R E V I E W S
              (Revised September 1997)
Current Science Reviews is revised
of the CSR. As the revisions are
discard any earlier Index. The CSRs
of those listmembers interested in the
a slightly more detailed explanation of
see the Introduction dated June 97.
CSR SOURCE JOURNAL JOURNAL REF.
                   DATE
1996;46:1051-1054
1993;8:240-241
Jun 96 Neur 1995;458-460
1996;47:705-711
27 Jul 1996:255
1995;45S3:S5
1994;8:1511-1513
17 Aug 1996
1995;37:300-312
" " Nov 96 J Neur N'surg Psych 1996;61:391-387
1996;46:1551-1556
97 Br J Clin Pharmacol 1997;43:119-121
1996;47:1512-1517
1997;12:190-195
1997;49:310-311
96 J Neur N'surg Psych 1996;61:347-351
94 J Neur N'surg Psych 1994;8:998-1001
, " Aug 96 J Neur N'surg Psych 1996;61:634-637
, " May 97 J Clin Neuropharm 1997;20:165-167
, " Sep 97 J Clin Neuropharm 1997;20:245-252
, availability Apr 95 Lancet 1995;345:517-518
self-injection Jul 95 J Neur N'surg Psych 1995;58:681-687
May 97 J Clin Neuropharm 1997;20:140-147
1995;38:839-851
Dec 96 Science News 16 Nov 96:316
Mar 97 Science 21 Feb 97;1081-82
Apr 97 J Neurosci 1997;17:1075-1085
Apr 97 J Neurosci 1007;17:1397-1405
,l-dopa induced Feb 97 Mov Disord 1997;12:17-23
1997;20:311-321
1997;41:133
1997;48:662-667
97 J Neur N'surg Psych 1996;61:645-648
1997;12:306-314
1996;16:7308-7330
1995;45:822-824
Aug 96 Archives of Neur 1996;53:617-624
Aug 96 J Neur N'surg Psych 1996;61:693
95 J Neur N'surg Psych 1995;58:688-691
1996;47:1358-1359
1996;119:801-813
94 J Neur N'surg Psych 1994;8:903-910
Mar 96 Lancet 20 Jan 1996:196
plus levodopa May 97 Clin Neuropharm 1997;20;67-76
1997;12:73-78
1994;51:1236-1241
Dec 95 Lancet 11 Nov 1995:1290
Jun 96 Neur 1996;46:1062-1065
Mar 97 Neur 1997;48:363-368
1997:12:612-613
1997;12:608-610
1996:47:705-711
1996;46:1200-1205
" Jun 96 Ann Neur 1996;39:650-658
,cognition in May 97 Science 28 Mar 97:1940-43
21 Sep 96:834
1997;12:107-110
1997;12:423-425
28 Jun 97:1877-81
1995;345:517-518
Apr 95 Neur 1995;45:432-434
Jan 97 BMJ 16 Nov 1996:1313
Sep 97 J Neur N'surg Psych 199763:120
Sep 97 J Clin Neuropharm 1997;20:201-209
for dyskinesia Apr 97 Neur 1997;48:658-662
relieves "off" May 97 Mov Disord 1997;12:159-166
May 97 Neur 1997;48:1077-1091
Sep 97 Mov Disord 11997;12:483-496
1996;16:7670-7677
95 J Neur N'surg Psych 1995;58:51-55
Jun 96 J Neur N'surg Psych 1996;60:564-571
Jan 97 J Neurosci 1996;16:7768-7775
Mar 97 Brain 1996;119:2121-32
Mar 97 Neur 1997;48:546-547
Apr 97 Arch Neur 1997;54:296-302
Sep 97 Arch Neur 1997;54:947-950
1995;45:386-387
Jul 95 Brain 1995;118:771-778
1996;40:663-671
Feb 97 Mov Disord 1997;12:3-8
1995;346:861-864
Aug 97 Mov Disord 1997:12:423-425
1995;52:565-570
Mar 96 Ann Neur 1996;39:29-36
Mar 97 Ann Neur 1996;40:946-949
, end point in May 97 Mov Disord 1997;12:183-189
96 Arch Neur
Jun 96 Neur
Aug 97 Neur 1997;49:259-253
vs pallidotomy Jul 97 Nat Med 1997;3:671-674
" Jul 97 Nat Med 1997;3:602-603
Aug 97 Mov Disord 1997;12:337-341
1995;45:1025
Apr 97 J Neur N'surg Psych 1997;62:289
,frontotemporal Jul 97 Ann Neur 1997;41:706-715
, preclinical Jan 96 Neur 1995;45:1691-1696
Jun 96 Neur 1995;45:705-708
" Jul 96 Arch Neur 1996;53:538-542
, tacrine for Oct 96 J Neur N'surg Psych 1996;61:324-325
, wine prevents May 97 BMJ 5 Apr 97:997
1996;53:175-179
Jan 97 Neur 1996;47:1148-1152
Jun 97 Arch Neur 1997;54:625-630
1997;120:75-90
" Apr 97 J Neur N'surg Psych 1997;62:245-252
" Sep 97 J Clin Neuropharm 1997;20:239-244
1997;68:434-436
96 J Neur N'surg Psych 1996;60:531-538
Sep 96 Neur 1996;47:462-466
8 Mar 97:689-690
receptors Nov 96 J Neurosci 1996;16:6579-6591
" Feb 97 Mov Disord 1997;12:33-38
" Jul 97 Neur 1997;48:1589-1593
storage sites Nov 96 J Neurosci 1996;16:4135-4145
transporter Mar 96 Science 16 Feb 1996:909
" Apr 97 J Neurosci 1997;17:960-974
" Jul 97 Neur 1997;48:1578-1583
1994;44:2419
17 Jan 1996:182
Aug 96 J Neur N'surg Psych 1996;61:621-627
21 Oct 1996:92
Sep 97 Ann Neur 1997;42:Aug
1997;49S1:S2-S62
1996;46:1548-1551
Mar 97 Neur 1997;48:369-372
, clozapine for Apr 97 Neur 1997;48:658-682
, DA-induced May 97 Mov Disord 1997;12:148-158
1994;36;759-764
1996;46:1284-1286
(PD) Aug 96 J Neur N'surg Psych 1996;61:693-694
96 J Neur N'surg Psych 1996;60:589
96 J Neur N'surg Psych 1996;60:36-40
Sep 97 Mov Disord 1997;12:497-505
25 Apr 96:1106-15
1996;46:1150-1153
,aminophylline Sep 97 Br J Clin Pharmacol 1997;43:119-121
, and PD Jun 96 Neur 1995;45:645-648
, botulinum Jun 96 Neur 1995;45:822-824
, and DBS Aug 97 Mov Disord 1997;12:337-341
, migraine Jun 96 Neur 1996;46:458-460
, etiology Jun 96 Neur 1996;46:1200-1205
" Sep 96 Neur 1996;47:264-265
" Mar 97 Ann Neur 1997;411:32-40
" Aug 97 J Neurol Sci 1997;149:195-196
" Sep 97 Neuroepidemiology 1997;16:124-133
" Sep 97 Arch Neur 1997;54:289-254
" Sep 97 Arch Neur 1997;54:197-200
, PET scan Jun 96 Ann Neur 1996;39:650-658
" Jan 97 Neur 1996;47:1331-1332
1996;39:650-658
Mar 97 Ann Neur 1996;40:950
1996;46:1044-1050
Jun 96 Neur 1996;46:1270-1274
Jun 96 Neur 1996;46:1275-1284
Aug 96 J Neur N'surg Psych 1996;61:4-16
Sep 96 Arch Neur 1996;53;721
Oct 96 Neur 1996;47:636-643
Oct 96 Neur 1996;47:644-650
Mar 97 Arch Neur 1997;54:145-150
Apr 97 Neur 1997;48:650-658
1995;45:1696-1702
1994;44:2285
1995;38:379-388
Apr 96 Brain 1996;119:41-50
Dec 96 Lancet 26 Oct 1996;1159
Jul 97 Neur 1997;48:1737-1738
Apr 97 Lancet 16 Mar 1997;784
Nov 95 Science News 7 Oct 1995:230
Mar 97 Science 24 Jan 1997:473
Apr 97 BMJ 1 Mar 1997;625
Jul 97 Nat Med 1997;3:474-475
Aug 97 Nat Med 1997;3:350-353
research Dec 96 J Neurosci 1996;16:6966-6974
" Dec 96 J Neurosci 1996;16:7216-7227
Jul 97 J Neurosurg 1997;86:931-942
, survival Aug 97 Exp Neur 1997;144:41-46
" Aug 97 Ann Neur 1997;42:95-107
1997:12:285-292
1996;47:1180-1183
1997;12:107-110
1997;3:477
1996;47:636-643
18 May 1996:311
1997;12:302-305
1997;12:206-215
1997;20:148-151
for PD Sep 97 Mov Disord 1997;12:608
1996;119:551-558
Jan 97 Brain 1996;119:1705-16
Sep 97 J Clin Neuropharm 1997;20:183-184
1996;39:535-538
1995;45:1149-1154
1996;16:7206-7215
Jan 97 J Neurosci 1996;16:8132-8139
Mar 97 Science 7 Feb 97:838-841
Sep 97 Ann Neur 1997;42:208-214
1996;47:225-230
1995;345:958
Jan 96 Neur 1995;45:1760-1763
Dec 96 Science 15 Nov 96;1197-99
Jan 97 BMJ 23 Nov 96;1278
Jan 97 Ann Neur 1996;40:767-775
Mar 97 Ann Neur 1997;41:277-281
Jul 97 Ann Neur 1997;41:814
Aug 97 Science 27 Jun 97:2045
Aug 97 Science News 28 Jun 97:396
29 Jul 1995:73
May 96 Science 12 Apr 1996;263
Aug 97 Nat Med 1997;3:357-359
Aug 97 Brain 1997;120:1245-59
1994;69:125-130
1996;39:574-578
Jun 96 Ann Neur 1996;39:557-558
Nov 96 J Neurosci 1996;16:4231-4239
Sep 97 J Clin Neuropharm 1997:20:311-321
Nov 96 J Neurosci 1996;16:6394-6401
, toxicity Jan 97 Science 6 Dec 1996:1612
1996;47:219-224
1995;38:218-224
1995;45:659-671
Jan 97 Arch Neur 1996;53:1265-1268
Sep 97 J Neur N'surg Psych 1997;63:120
1995;45:502-506
Oct 95 Ann Neur 1995;38:373-378
Feb 96 Science News 6 Jan 96:4
Jun 96 Neur 1996;46:1275-1284
Sep 96 Neur 1996;47:155-160
Sep 96 Neur 1996;47:160-166
Mar 97 Ann Neur 1997;41:265-268
Mar 97 Ann Neur 1997;41:222-229
1996;46:1693-1696

Top of Message | Previous Page | Permalink

Search Archives

Advanced Options

Options

		Log In
		Get Password

		Search Archives

		Subscribe or Unsubscribe

Archives

ATOM RSS1 RSS2

LISTSERV.UTORONTO.CA